title: MEL-P, a GM-CSF-producing human melanoma cell line.
abstract: A human melanoma cell line, MEL-P, expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) and its specific receptor was newly established from a primary nodular lesion of a patient with a particularly unfavourable prognosis. Cytogenetic, immunophenotypic, cytokine and intercellular adhesion molecule (ICAM)-1 production analyses confirmed that this cell line was similar to the fresh melanoma cells from which it had been established. MEL-P constitutes a valuable model for the study of multistep tumour progression and the role of biologically active GM-CSF production in human malignant melanoma. Our results show a decreasing expression of HLA class I molecules during in vitro culture, when GM-CSF secretion attains the highest levels, and a constantly high production of ICAM-1. The inhibitory effect of GM-CSF antisense treatment on cellular growth might suggest the presence of an autocrine mechanism. On the whole, these data are consistent with the possible involvement of high GM-CSF production in the metastatic competence of melanoma cells through the autocrine mechanism of growth and/or the activation of other migration-related molecules by its local production in metastatic invasion.
authors.affiliation: Institute of Biology and Genetics, Genoa, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Ciotti
authors.forename: A
authors.initials: A
authors.lastname: Imro
authors.forename: M
authors.initials: M
authors.lastname: Scudeletti
authors.forename: M L
authors.initials: ML
authors.lastname: Rainero
authors.forename: R
authors.initials: R
authors.lastname: Defferrari
authors.forename: P
authors.initials: P
authors.lastname: Ghiorzo
authors.forename: F
authors.initials: F
authors.lastname: Indiveri
authors.forename: G
authors.initials: G
authors.lastname: Bianchi-Scarrà
mesh_terms: D000328:Adult; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002869:Chromosome Aberrations; D046508:Culture Techniques / Q000379:methods; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000096:biosynthesis*; D006258:Head and Neck Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D006801:Humans; D016130:Immunophenotyping; D007621:Karyotyping; D007700:Kinetics; D008297:Male; D008545:Melanoma / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D016187:Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / Q000096:biosynthesis*; D012878:Skin Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D014407:Tumor Cells, Cultured
chemical_list: D016376:Oligonucleotides, Antisense; D012333:RNA, Messenger; D016187:Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor